Life ScienceCompany
Tocagen - Replicating Gene Therapy Platform and Related Assets Ownership
Who owns Tocagen - Replicating Gene Therapy Platform and Related Assets?
Tocagen - Replicating Gene Therapy Platform and Related Assets is owned by Denovo Biopharma. It was acquired on April 28, 2020.
Tocagen - Replicating Gene Therapy Platform and Related Assets Business Overview
Where is Tocagen - Replicating Gene Therapy Platform and Related Assets headquartered?
Tocagen - Replicating Gene Therapy Platform and Related Assets is headquartered in California.
What sector is Tocagen - Replicating Gene Therapy Platform and Related Assets in?
Tocagen - Replicating Gene Therapy Platform and Related Assets is a life science company.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 291 acquisitions of life science companies in 2020, including 24 acquisitions by private equity firms, and 267 by strategics.